Hostname: page-component-78c5997874-g7gxr Total loading time: 0 Render date: 2024-11-13T01:13:43.814Z Has data issue: false hasContentIssue false
  • English
  • Français

Commentary on: Subjective cognitive decline is longitudinally associated with lower health-related quality of life

Published online by Cambridge University Press:  02 October 2017

Claudia Cooper
Claudia Cooper*
Affiliation:
University College London, Division of Psychiatry, London, UK
*
Email: [email protected]
Get access Rights & Permissions [Opens in a new window]

Extract

Public campaigns to encourage early detection of dementia in the developed world have led to identification of more people with mild cognitive impairment (MCI) or subjective cognitive decline (SCD). Early dementia diagnosis enables earlier information and support, including symptomatic treatments where appropriate. In clinical trials, detection of those with “prodromal dementia,” identified from cognitive symptoms and stratified by biomarkers (Schneider, 2010), enables potential disease modifying treatments to be targeted early in the disease process, where success is more likely.

Type
Commentary
Information
International Psychogeriatrics , Volume 29 , Issue 12 , December 2017 , pp. 1937
Copyright
Copyright © International Psychogeriatric Association 2017 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Roehr, S. et al. (2017). Subjective cognitive decline is longitudinally associated with lower health-related quality of life. International Psychogeriatrics, 1–12. doi:10.1017/S1041610217001399.Google Scholar
Schneider, L. S. (2010). The potential and limits for clinical trials for Early Alzheimer's disease and some recommendations. Journal of Nutrition Health & Aging, 14, 295–298.CrossRefGoogle ScholarPubMed